根据 Gen Consulting 公司发布的市场研究报告, the market size of the global pharmaceutical CDMO sector is expected to rise by USD 78.0 亿，复合年增长率为 6.2% 到年底 2028.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global pharmaceutical CDMO market. 它追踪市场的历史和预测市场增长. 该报告根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the pharmaceutical CDMO industry.

该行业报告提供了全球市场的市场估计和预测, followed by a detailed analysis of the CMO type, CRO research phase, 和地区. The global market for pharmaceutical CDMO can be segmented by CMO type: 活性药物成分 (应用程序编程接口) 制造业, 成品剂量配方 (FDF) 开发与制造, 二次包装. The active pharmaceutical ingredient (应用程序编程接口) manufacturing segment is estimated to account for the largest share of the global pharmaceutical CDMO market. Pharmaceutical CDMO market is further segmented by CRO research phase: 临床前, 第一阶段, 第二阶段, 第三阶段, 第四阶段. The phase III segment held the largest revenue share in 2021. 根据地区, the pharmaceutical CDMO market is segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 全球范围, North America made up the largest share of the pharmaceutical CDMO market.

The finished dosage formulation (FDF) development and manufacturing market is further segmented into solid dose formulation, liquid dose formulation, injectable dose formulation. The solid dose formulation segment held the largest share of the global pharmaceutical CDMO market in 2021 预计在预测期内将持有其份额. 此外, the API manufacturing market has been categorized into small molecule, large molecule, high potency API (HPAPI). 在 2021, the small molecule segment made up the largest share of revenue generated by the pharmaceutical CDMO market.

市场细分
By CMO type: 活性药物成分 (应用程序编程接口) 制造业, 成品剂量配方 (FDF) 开发与制造, 二次包装
By CRO research phase: 临床前, 第一阶段, 第二阶段, 第三阶段, 第四阶段
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report has also analysed the competitive landscape of the global pharmaceutical CDMO market with some of the key players being Baxter Pharmaceutical Solutions LLC, Boehringer Ingelheim GmbH, Catalent Inc., CMIC Holdings Co., 有限公司, Covance Inc., Hangzhou Tigermed Consulting Co., 有限公司, ICON plc, IQVIA Holdings Inc., Jubilant Life Sciences Ltd., 龙沙集团公司, Novotech Pty Ltd., PAREXEL International Corporation, Patheon Inc., Pfizer CentreSource, PPD, 公司, Recipharm AB, Samsungbioepis Co,. 有限公司, Syneos Health Inc., WuXi AppTec Inc., 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
– To analyze and forecast the market size of the global pharmaceutical CDMO market.
– To classify and forecast the global pharmaceutical CDMO market based on CMO type, CRO research phase, 地区.
– To identify drivers and challenges for the global pharmaceutical CDMO market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global pharmaceutical CDMO market.
– To identify and analyze the profile of leading players operating in the global pharmaceutical CDMO market.

为什么选择这份报告
– Gain a reliable outlook of the global pharmaceutical CDMO market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.